A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin (Q33540751)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gewirtz DA

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

727-741

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Some effects of daunomycin on the nucleic acid synthesis in synchronized L-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interaction of daunomycin and its derivatives with DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin and Daunorubicin Inhibition of Mutant T4 DNA Polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The Interaction of Daunomycin with Polydeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Mechanism of the inhibition of calf thymus DNA polymerases alpha and beta by daunomycin and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline antibiotics. Interaction with DNA and nucleosomes and inhibition of DNA synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Deoxyribose breakdown by the adriamycin semiquinone and H2O2: evidence for hydroxyl radical participation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Oxidative destruction of DNA by the adriamycin-iron complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Hydroxyl radical production and DNA damage induced by anthracycline-iron complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radical damage to deoxyribose by anthracycline, aureolic acid and aminoquinone antitumour antibiotics. An essential requirement for iron, semiquinones and hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radicals in anticancer drug pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dependence of nucleic acid degradation on in situ free-radical production by Adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Two mechanisms of adriamycin-DNA interaction in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced lipid peroxidation in mitochondria and microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Lipid peroxidation, phosphoinositide turnover and protein kinase C activation in human platelets treated with anthracyclines and their complexes with Fe(III)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Measurement of doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Evaluation of adriamycin-induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA sequence-specific adducts of adriamycin and mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Induction of stable transcriptional blockage sites by Adriamycin: GpC specificity of apparent Adriamycin-DNA adducts and dependence on iron(III) ions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The consequences of doxorubicin quinone reduction in vivo in tumour tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Formation of adriamycin--DNA adducts in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interstrand DNA crosslinking induced by anthracyclines in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA unwinding and inhibition of T4 DNA ligase by anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Correlation between anthracycline structure and human DNA ligase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inhibition of DNA Unwinding and ATPase Activities of Human DNA Helicase II by Chemotherapeutic Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline antibiotic blockade of SV40 T antigen helicase action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline glycoside-membrane interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The anticancer agent adriamycin can be actively cytotoxic without entering cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Pharmacokinetics and metabolism of adriamycin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

PCNA: structure, functions and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Clinical pharmacokinetics of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radical modes of cytotoxicity of adriamycin and streptonigrin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Early and delayed clinical cardiotoxicity of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Serum lipid peroxides in rats treated chronically with adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin induced alterations in lipid metabolism of cultured myocardial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA double-strand breaks in mammalian cells after exposure to intercalating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Repair of deoxyribonucleic acid lesions caused by adriamycin and ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracyclines with different sequence specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The Cause of G2-Arrest in Chinese Hamster Ovary Cells Treated With Anticancer Drugs2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

G2 block induced by DNA crosslinking agents and its possible consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

p16INK4A Participates in a G1 Arrest Checkpoint in Response to DNA Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dose-dependence of doxorubicin effect on actin assembly in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The molecular pharmacology of doxorubicin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00307-4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33540751&oldid=1584572790"